Why This Landed on My Radar
Ohio University just landed a $4 million NIH grant to scale a mentor-based model that gets primary care docs comfortably prescribing buprenorphine without the typical headaches. What caught my attention isn’t the grant itself-it’s that they’re proving you don’t need to become an addiction specialist to treat opioid use disorder in your practice. With Texas leading the nation in uninsured patients and rural communities hemorrhaging specialty access, this model addresses a gap most of us are seeing but not filling.
Here’s What’s Going On
Berkeley Franz and her team at Ohio University Heritage College of Osteopathic Medicine are expanding a pilot program that pairs primary care providers with experienced addiction medicine prescribers in a structured mentorship model. The four-year study will roll out across roughly 40 clinics in Ohio and West Virginia, partnering with community health centers and regional health systems to embed opioid use disorder treatment directly into routine primary care.
The approach is deliberately “low touch”-streamlined training followed by ongoing support from prescribers at Grant Medical Center’s Fellowship in Addiction Medicine. It’s designed for rural providers who may not have another OUD prescriber in their entire network. The study isn’t testing whether buprenorphine works (that science is settled), but whether a brief mentorship model can sustainably move this treatment from specialty referrals into the primary care setting where patients are already showing up.
Franz frames it bluntly: “We’re not asking whether it works-we’re asking how we get it into routine primary care in a way that’s sustainable.” The pilot showed promising results, and now they’re testing whether it scales in real-world conditions with patient outcomes tracked over time.
What This Means for Your Practice
Let’s be honest-most of us didn’t go into primary care planning to treat addiction, but our patient panels don’t care about our original career plans. In Texas, this hits different. We’ve got the largest uninsured population in the country, no Medicaid expansion to catch people in crisis, and vast rural stretches where the nearest addiction specialist might be 90 miles away. When a patient struggling with opioid use disorder shows up in your office, your options are typically: refer to a program they can’t afford or can’t reach, or watch them cycle through the ED.
The traditional barrier has been knowledge and confidence, not regulation. The X-waiver requirement was eliminated in 2023, meaning any DEA-licensed provider can prescribe buprenorphine without additional certification. Yet most of us still don’t. Why? Because we weren’t trained in it, we don’t have colleagues down the hall to consult, and the patients feel complex when you’re managing twenty other chronic conditions across a full panel.
This is where the Ohio model gets interesting for Texas practices. A structured mentorship approach-especially one proven in rural settings-could be exactly what converts this from “someone else’s job” to “something I can manage like diabetes or hypertension.” Think about your panel composition. In urban markets like Houston or Dallas, you’re competing with urgent care chains and retail clinics for straightforward visits. Your value proposition is managing complexity and building longitudinal relationships. Adding MAT capacity differentiates you and keeps patients in your ecosystem rather than losing them to fragmented specialty care they may never access.
For rural practices, it’s even more fundamental. You’re already the safety net. If you’re not treating OUD, it’s probably not getting treated. And untreated addiction means missed appointments, uncontrolled comorbidities, higher ED utilization, and poor outcomes across your entire patient population. From a pure business perspective, these are high-touch patients with chronic disease who need regular follow-up-exactly the kind of longitudinal care that should be the bread and butter of independent primary care, especially as value-based arrangements reward managing complex populations.
The mentor model also addresses the isolation factor. Most of us practice without easy access to specialists for curbside consults. Having a structured pathway to an experienced prescriber while you’re building confidence could be the difference between starting or continuing to punt.
Key Takeaways
- The X-waiver is gone-any DEA-licensed provider can prescribe buprenorphine, but most still don’t due to training gaps, not regulatory barriers
- Structured mentorship models are proving that primary care docs can manage OUD without becoming addiction specialists
- In Texas’s uninsured-heavy, no-Medicaid-expansion environment, you may be the only accessible treatment option for these patients
- Adding MAT capacity differentiates your practice in competitive urban markets and fills critical gaps in rural communities
- This is longitudinal chronic disease management-exactly what independent primary care should excel at, especially under value-based models
What Smart Practices Are Doing
The forward-thinking practices I’m seeing aren’t waiting for the perfect system-they’re identifying one or two providers willing to start, connecting with virtual or regional mentorship networks, and building competency one patient at a time. They’re also looking at how their practice management systems can support this population with structured follow-up protocols and tracking, turning what feels like uncharted territory into another chronic disease workflow.
Source
“Ohio University Researchers Expand Opioid Use Disorder Treatment with Nearly $4 Million NIH Grant to Improve Rural Primary Care Access” - Ohio University News
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition